-transparent.png){kind=logo}
We studied the effect of ergotamine on the formation of metabolites of [1 - 14C] arachidonic acid by human blood platelets incubated with ergotamine (10(-5) or 5.10(-5)M) in vitro or after 0.5 mg i.m. administration in vivo. The in vitro experiments confirmed our earlier observation that ergotamine inhibits prostaglandin synthesis. This effect, however, seemed to be restricted to the toxic dose range of the drug as in vivo it occurred only in those subjects who became nauseated or vomited after administration of the drug.
Related Publications
F J Zijlstra, and
E L Spierings, and
J E Vincent
May 1967,
British medical journal,
F J Zijlstra, and
E L Spierings, and
J E Vincent
November 1970,
British journal of haematology,
F J Zijlstra, and
E L Spierings, and
J E Vincent
April 1987,
Methods and findings in experimental and clinical pharmacology,
F J Zijlstra, and
E L Spierings, and
J E Vincent
January 1979,
Journal of studies on alcohol,
F J Zijlstra, and
E L Spierings, and
J E Vincent
January 1978,
Thrombosis research,
F J Zijlstra, and
E L Spierings, and
J E Vincent
November 1981,
The Journal of pharmacology and experimental therapeutics,
F J Zijlstra, and
E L Spierings, and
J E Vincent
January 1980,
Immunological communications,
F J Zijlstra, and
E L Spierings, and
J E Vincent
September 1988,
Investigative radiology,
F J Zijlstra, and
E L Spierings, and
J E Vincent
October 1983,
Wiener klinische Wochenschrift,
F J Zijlstra, and
E L Spierings, and
J E Vincent
December 2003,
Experimental biology and medicine (Maywood, N.J.),
